{"id":10,"date":"2024-11-27T18:37:18","date_gmt":"2024-11-27T18:37:18","guid":{"rendered":"https:\/\/www.adarx.com\/?page_id=10"},"modified":"2026-09-07T18:29:42","modified_gmt":"2026-09-08T01:29:42","slug":"pipeline","status":"publish","type":"page","link":"https:\/\/www.adarx.com\/dev\/pipeline\/","title":{"rendered":"Pipeline"},"content":{"rendered":"<table class=\"pipeline_cont pipeline-desk\"><tr><th class='myth column-1'>Program\/Technology<\/th><th class='myth column-2'>Target<\/th><th class='myth column-3'>Indication<\/th><th class='myth column-4'>Discovery<\/th><th class='myth column-5'>IND-enabling<\/th><th class='myth column-6'>Phase 1<\/th><th class='myth column-7'>Phase 2<\/th><th class='myth column-8'>Phase 3<\/th><th class='myth column-9'>Ownership<\/th><\/tr><tr><td class='mydTitle' colspan='9'>Hepatic<\/td><\/tr>\n<td class='drug_detailsX'>Agazisiran<i class='fas fa-sort-amount-down-alt' aria-hidden='true'><\/i><\/td>\n<td class='drug_detailsY'>CFB<\/td>\n<td class='drug_detailsY'>Renal (IgAN, C3G, IC-MPGN)<\/td><td class='drug_progress' colspan='5'><div data-width='70'><\/div><span class='arrow'>&nbsp;<\/span><\/td>\n<td class='drug_detailsXY'><img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/td><\/tr><tr><td class='pipe-info' colspan='9'><div class='table-data-box'><p class='table-data-header'>Agazisiran, <span>Renal (IgAN, C3G, IC-MPGN)<\/span><\/p><div class='table-data-copy'><\/div><p class='table-data-close'><i class='fas fa-sort-amount-up-alt' aria-hidden='true'><\/i>Close<\/p><\/div><\/td><\/tr><tr id='row-1-s-0'>\n<td class='drug_detailsX'>Agazisiran<i class='fas fa-sort-amount-down-alt' aria-hidden='true'><\/i><\/td>\n<td class='drug_detailsY'>CFB<\/td>\n<td class='drug_detailsY'>PNH<\/td><td class='drug_progress' colspan='5'><div data-width='70'><\/div><span class='arrow'>&nbsp;<\/span><\/td>\n<td class='drug_detailsXY'><img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/td><\/tr><tr><td class='pipe-info' colspan='9'><div class='table-data-box'><p class='table-data-header'>Agazisiran, <span>PNH<\/span><\/p><div class='table-data-copy'><\/div><p class='table-data-close'><i class='fas fa-sort-amount-up-alt' aria-hidden='true'><\/i>Close<\/p><\/div><\/td><\/tr><tr id='row-2-s-0'>\n<td class='drug_detailsX'>Agazisiran<i class='fas fa-sort-amount-down-alt' aria-hidden='true'><\/i><\/td>\n<td class='drug_detailsY'>CFB<\/td>\n<td class='drug_detailsY'>GA<\/td><td class='drug_progress' colspan='5'><div data-width='70'><\/div><span class='arrow'>&nbsp;<\/span><\/td>\n<td class='drug_detailsXY'><img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/td><\/tr><tr><td class='pipe-info' colspan='9'><div class='table-data-box'><p class='table-data-header'>Agazisiran, <span>GA<\/span><\/p><div class='table-data-copy'><\/div><p class='table-data-close'><i class='fas fa-sort-amount-up-alt' aria-hidden='true'><\/i>Close<\/p><\/div><\/td><\/tr><tr id='row-3-s-0'>\n<td class='drug_detailsX'>Onvuzosiran<i class='fas fa-sort-amount-down-alt' aria-hidden='true'><\/i><\/td>\n<td class='drug_detailsY'>PKK<\/td>\n<td class='drug_detailsY'>HAE<\/td><td class='drug_progress' colspan='5'><div data-width='85'><\/div><span class='arrow'>&nbsp;<\/span><\/td>\n<td class='drug_detailsXY'><img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/td><\/tr><tr><td class='pipe-info' colspan='9'><div class='table-data-box'><p class='table-data-header'>Onvuzosiran, <span>HAE<\/span><\/p><div class='table-data-copy'><\/div><p class='table-data-close'><i class='fas fa-sort-amount-up-alt' aria-hidden='true'><\/i>Close<\/p><\/div><\/td><\/tr><tr id='row-4-s-0'>\n<td class='drug_detailsX'>ADX-626<i class='fas fa-sort-amount-down-alt' aria-hidden='true'><\/i><\/td>\n<td class='drug_detailsY'>FXI<\/td>\n<td class='drug_detailsY'>Secondary Stroke Prevention & Stroke Prevention in AFib<\/td><td class='drug_progress' colspan='5'><div data-width='49'><\/div><span class='arrow'>&nbsp;<\/span><\/td>\n<td class='drug_detailsXY'><img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/td><\/tr><tr><td class='pipe-info' colspan='9'><div class='table-data-box'><p class='table-data-header'>ADX-626, <span>Secondary Stroke Prevention & Stroke Prevention in AFib<\/span><\/p><div class='table-data-copy'><\/div><p class='table-data-close'><i class='fas fa-sort-amount-up-alt' aria-hidden='true'><\/i>Close<\/p><\/div><\/td><\/tr><tr><td class='mydTitle' colspan='9'>Extrahepatic<\/td><\/tr>\n<td class='drug_detailsX'>ADX-077<i class='fas fa-sort-amount-down-alt' aria-hidden='true'><\/i><\/td>\n<td class='drug_detailsY'>Undisclosed<sup>1<\/sup><\/td>\n<td class='drug_detailsY'>Obesity<\/td><td class='drug_progress' colspan='5'><div data-width='28'><\/div><span class='arrow'>&nbsp;<\/span><\/td>\n<td class='drug_detailsXY'><img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/td><\/tr><tr><td class='pipe-info' colspan='9'><div class='table-data-box'><p class='table-data-header'>ADX-077, <span>Obesity<\/span><\/p><div class='table-data-copy'><\/div><p class='table-data-close'><i class='fas fa-sort-amount-up-alt' aria-hidden='true'><\/i>Close<\/p><\/div><\/td><\/tr><tr id='row-1-s-1'>\n<td class='drug_detailsX'>ADX-199<i class='fas fa-sort-amount-down-alt' aria-hidden='true'><\/i><\/td>\n<td class='drug_detailsY'>APP<\/td>\n<td class='drug_detailsY'>Neurodegeneration<\/td><td class='drug_progress' colspan='5'><div data-width='17'><\/div><span class='arrow'>&nbsp;<\/span><\/td>\n<td class='drug_detailsXY'><img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/td><\/tr><tr><td class='pipe-info' colspan='9'><div class='table-data-box'><p class='table-data-header'>ADX-199, <span>Neurodegeneration<\/span><\/p><div class='table-data-copy'><\/div><p class='table-data-close'><i class='fas fa-sort-amount-up-alt' aria-hidden='true'><\/i>Close<\/p><\/div><\/td><\/tr><\/tbody><\/table><table class=\"pipeline_cont pipeline-mobile\"><tr><td class='mydTitle' colspan='5'>Hepatic<\/td><\/tr><tr class='mobile-chart-heading'><td>Discovery<\/td><td>IND-enabling<\/td><td>Phase 1<\/td><td>Phase 2<\/td><td>Phase 3<\/td><\/tr>\n<tr><td colspan='5' class='drug_info'><p class='drug_detailsX'>Agazisiran&nbsp;&nbsp;<span class='drug_detailsY'>Target: CFB | <\/span><span class='drug_detailsY'>Indication: Renal (IgAN, C3G, IC-MPGN)<\/span><\/p><p class='drug_detailsXY'>Ownership:<img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/p><\/td><\/tr><tr><td colspan='5' class='drug_progress'><div data-width='70'><\/div><span class='arrow'>&nbsp;<\/span><\/td>\n<tr><td colspan='5' class='drug_info'><p class='drug_detailsX'>Agazisiran&nbsp;&nbsp;<span class='drug_detailsY'>Target: CFB | <\/span><span class='drug_detailsY'>Indication: PNH<\/span><\/p><p class='drug_detailsXY'>Ownership:<img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/p><\/td><\/tr><tr><td colspan='5' class='drug_progress'><div data-width='70'><\/div><span class='arrow'>&nbsp;<\/span><\/td>\n<tr><td colspan='5' class='drug_info'><p class='drug_detailsX'>Agazisiran&nbsp;&nbsp;<span class='drug_detailsY'>Target: CFB | <\/span><span class='drug_detailsY'>Indication: GA<\/span><\/p><p class='drug_detailsXY'>Ownership:<img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/p><\/td><\/tr><tr><td colspan='5' class='drug_progress'><div data-width='70'><\/div><span class='arrow'>&nbsp;<\/span><\/td>\n<tr><td colspan='5' class='drug_info'><p class='drug_detailsX'>Onvuzosiran&nbsp;&nbsp;<span class='drug_detailsY'>Target: PKK | <\/span><span class='drug_detailsY'>Indication: HAE<\/span><\/p><p class='drug_detailsXY'>Ownership:<img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/p><\/td><\/tr><tr><td colspan='5' class='drug_progress'><div data-width='85'><\/div><span class='arrow'>&nbsp;<\/span><\/td>\n<tr><td colspan='5' class='drug_info'><p class='drug_detailsX'>ADX-626&nbsp;&nbsp;<span class='drug_detailsY'>Target: FXI | <\/span><span class='drug_detailsY'>Indication: Secondary Stroke Prevention & Stroke Prevention in AFib<\/span><\/p><p class='drug_detailsXY'>Ownership:<img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/p><\/td><\/tr><tr><td colspan='5' class='drug_progress'><div data-width='49'><\/div><span class='arrow'>&nbsp;<\/span><\/td><tr><td class='mydTitle' colspan='5'>Extrahepatic<\/td><\/tr><tr class='mobile-chart-heading'><td>Discovery<\/td><td>IND-enabling<\/td><td>Phase 1<\/td><td>Phase 2<\/td><td>Phase 3<\/td><\/tr>\n<tr><td colspan='5' class='drug_info'><p class='drug_detailsX'>ADX-077&nbsp;&nbsp;<span class='drug_detailsY'>Target: Undisclosed<sup>1<\/sup> | <\/span><span class='drug_detailsY'>Indication: Obesity<\/span><\/p><p class='drug_detailsXY'>Ownership:<img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/p><\/td><\/tr><tr><td colspan='5' class='drug_progress'><div data-width='28'><\/div><span class='arrow'>&nbsp;<\/span><\/td>\n<tr><td colspan='5' class='drug_info'><p class='drug_detailsX'>ADX-199&nbsp;&nbsp;<span class='drug_detailsY'>Target: APP | <\/span><span class='drug_detailsY'>Indication: Neurodegeneration<\/span><\/p><p class='drug_detailsXY'>Ownership:<img src=https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/adarx-pipeline-logo.png><\/p><\/td><\/tr><tr><td colspan='5' class='drug_progress'><div data-width='17'><\/div><span class='arrow'>&nbsp;<\/span><\/td><\/tbody><\/table>\n\n\n\n<p class=\"footnotes wp-block-paragraph\">1) A novel, undisclosed target in adipose tissue, which we refer to as \u201cOBE1\u201d whose reduction in expression has been shown to reduce adiposity, with the objective to reduce body weight and fat while preserving lean mass.<br>AFib = Atrial Fibrillation; APP = Amyloid-\u03b2 Precursor Protein; C3G = Complement 3 Glomerulopathy; CFB = Complement Factor B; FXI = Factor XI; GA = Geographic Atrophy; HAE = Hereditary Angioedema; IC-MPGN = Immune Complex-Mediated Membranoproliferative Glomerulonephritis; IgAN = IgA Nephropathy; PKK = Prekallikrein; PNH = Paroxysmal Nocturnal Hemoglobinuria; SSP =\u00a0 Secondary Stroke Prevention<\/p>\n\n\n\n<p class=\"footnotes hide wp-block-paragraph\">1) A novel, undisclosed target in adipose tissue, which we refer to as \u201cOBE1\u201d whose reduction in expression has been shown to reduce adiposity, with the objective to reduce body weight and fat while preserving lean mass.<br>AFib = Atrial Fibrillation; APP = Amyloid-\u03b2 Precursor Protein; C3G = Complement 3 Glomerulopathy; CFB = Complement Factor B; eGFR = Estimated Glomerular Filtration Rate; FXI = Factor XI; GA = Geographic Atrophy; HAE = Hereditary Angioedema; Hb = Hemoglobin; IC-MPGN = Immune Complex-Mediated Membranoproliferative Glomerulonephritis; IgAN = IgA Nephropathy; PKK = Prekallikrein; PNH = Paroxysmal Nocturnal Hemoglobinuria; SSP =&nbsp; Secondary Stroke Prevention; UPCR = Urine Protein-Creatinine Ratio<\/p>\n\n\n<div id=\"pipeline-box\" class=\"div-cont\"><\/p>\n\n\n\n<div class=\"wp-block-columns is-not-stacked-on-mobile is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" src=\"https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2025\/05\/abbvie-pipeline-logov2.png\" alt=\"abbvie-pipeline-logov2\" class=\"wp-image-707\"\/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Discovery-stage extrahepatic programs leveraging ADARx\u2019s RNA discovery expertise and siRNA technology across indications in neuroscience, immunology and oncology<\/p>\n<\/div>\n<\/div>\n\n\n<p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>1) A novel, undisclosed target in adipose tissue, which we refer to as \u201cOBE1\u201d whose reduction in expression has been shown to reduce adiposity, with the objective to reduce body weight and fat while preserving lean mass.AFib = Atrial Fibrillation; APP = Amyloid-\u03b2 Precursor Protein; C3G = Complement 3 Glomerulopathy; CFB = Complement Factor B; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":471,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-10","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pipeline - ADARx Pharmaceuticals<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pipeline - ADARx Pharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"1) A novel, undisclosed target in adipose tissue, which we refer to as \u201cOBE1\u201d whose reduction in expression has been shown to reduce adiposity, with the objective to reduce body weight and fat while preserving lean mass.AFib = Atrial Fibrillation; APP = Amyloid-\u03b2 Precursor Protein; C3G = Complement 3 Glomerulopathy; CFB = Complement Factor B; [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adarx.com\/dev\/pipeline\/\" \/>\n<meta property=\"og:site_name\" content=\"ADARx Pharmaceuticals\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T01:29:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2024\/12\/pipeline-header-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"3840\" \/>\n\t<meta property=\"og:image:height\" content=\"1689\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/pipeline\\\/\",\"url\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/pipeline\\\/\",\"name\":\"Pipeline - ADARx Pharmaceuticals\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/pipeline\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/pipeline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/pipeline-header-1.jpg\",\"datePublished\":\"2024-11-27T18:37:18+00:00\",\"dateModified\":\"2026-09-08T01:29:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/pipeline\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.adarx.com\\\/dev\\\/pipeline\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/pipeline\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/pipeline-header-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/pipeline-header-1.jpg\",\"width\":3840,\"height\":1689,\"caption\":\"pipeline-header\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/pipeline\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pipeline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/#website\",\"url\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/\",\"name\":\"ADARx Pharmaceuticals\",\"description\":\"Providing hope for patients with intractable disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pipeline - ADARx Pharmaceuticals","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Pipeline - ADARx Pharmaceuticals","og_description":"1) A novel, undisclosed target in adipose tissue, which we refer to as \u201cOBE1\u201d whose reduction in expression has been shown to reduce adiposity, with the objective to reduce body weight and fat while preserving lean mass.AFib = Atrial Fibrillation; APP = Amyloid-\u03b2 Precursor Protein; C3G = Complement 3 Glomerulopathy; CFB = Complement Factor B; [&hellip;]","og_url":"https:\/\/www.adarx.com\/dev\/pipeline\/","og_site_name":"ADARx Pharmaceuticals","article_modified_time":"2026-09-08T01:29:42+00:00","og_image":[{"width":3840,"height":1689,"url":"https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2024\/12\/pipeline-header-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adarx.com\/dev\/pipeline\/","url":"https:\/\/www.adarx.com\/dev\/pipeline\/","name":"Pipeline - ADARx Pharmaceuticals","isPartOf":{"@id":"https:\/\/www.adarx.com\/dev\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.adarx.com\/dev\/pipeline\/#primaryimage"},"image":{"@id":"https:\/\/www.adarx.com\/dev\/pipeline\/#primaryimage"},"thumbnailUrl":"https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2024\/12\/pipeline-header-1.jpg","datePublished":"2024-11-27T18:37:18+00:00","dateModified":"2026-09-08T01:29:42+00:00","breadcrumb":{"@id":"https:\/\/www.adarx.com\/dev\/pipeline\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adarx.com\/dev\/pipeline\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.adarx.com\/dev\/pipeline\/#primaryimage","url":"https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2024\/12\/pipeline-header-1.jpg","contentUrl":"https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2024\/12\/pipeline-header-1.jpg","width":3840,"height":1689,"caption":"pipeline-header"},{"@type":"BreadcrumbList","@id":"https:\/\/www.adarx.com\/dev\/pipeline\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.adarx.com\/dev\/"},{"@type":"ListItem","position":2,"name":"Pipeline"}]},{"@type":"WebSite","@id":"https:\/\/www.adarx.com\/dev\/#website","url":"https:\/\/www.adarx.com\/dev\/","name":"ADARx Pharmaceuticals","description":"Providing hope for patients with intractable disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adarx.com\/dev\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/pages\/10","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/comments?post=10"}],"version-history":[{"count":18,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/pages\/10\/revisions"}],"predecessor-version":[{"id":1037,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/pages\/10\/revisions\/1037"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/media\/471"}],"wp:attachment":[{"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/media?parent=10"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}